Blog

BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

BOTHELL, Wash., April 23, 2026 /PRNewswire/ — BioLife Solutions, Inc.(NASDAQ: BLFS), a leading developer and supplier…

Silence at the chessboard changed how I talk to patients [PODCAST]

U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for trenibotulinumtoxinE (TrenibotE) related to…

Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Toward…

Brookdale Announces First Quarter 2026 Earnings Release and Conference Call Dates

BRENTWOOD, Tenn., April 23, 2026 /PRNewswire/ — Brookdale Senior Living Inc. (NYSE: BKD) will release its…

Rethinking nutrition policy on ultra-processed food

MURFREESBORO, Tenn., April 23, 2026 /PRNewswire/ — National Health Investors, Inc. (NYSE: NHI) announced today that…

NHI Announces CFO Succession Plan; John Spaid to Retire, Todd Siefert Named Successor

MURFREESBORO, Tenn., April 23, 2026 /PRNewswire/ — National Health Investors, Inc. (NYSE: NHI) announced today that…

5 patterns behind health care startups that fail

ATLANTA, April 23, 2026 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery…

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

ATLANTA, April 23, 2026 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery…

What a tiny dog taught me about the nervous system

SAN FRANCISCO, April 23, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused…

Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN FRANCISCO, April 23, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused…